Morbidity and mortality among patients with breast cancer receiving anticancer treatment before and during the COVID-19 pandemic: A single tertiary center experience.

Al-Hajeili, Marwan; Ujaimi, Reem; Iskanderani, Omar; Trabulsi, Nora; Bawazeer, Somayah

Al-Hajeili, Marwan; Ujaimi, Reem; Iskanderani, Omar; Trabulsi, Nora; Bawazeer, Somayah.

Afiliação

Al-Hajeili M; Department of Internal Medicine, Faculty of Medicine, King Abdulaziz University, Jeddah 22254, Kingdom of Saudi Arabia.
Ujaimi R; Department of Radiology, Faculty of Medicine, King Abdulaziz University, Jeddah 22254, Kingdom of Saudi Arabia.
Iskanderani O; Department of Radiology, Faculty of Medicine, King Abdulaziz University, Jeddah 22254, Kingdom of Saudi Arabia.
Trabulsi N; Department of Surgery, Faculty of Medicine, King Abdulaziz University, Jeddah 22254, Kingdom of Saudi Arabia.
Bawazeer S; Department of Community Medicine, Faculty of Medicine, King Abdulaziz University, Jeddah 22254, Kingdom of Saudi Arabia.

Oncol Lett ; 24(6): 454, 2022 Dec.

Article em En | MEDLINE | ID: mdl-36380880

Palavras-chave

COVID-19; breast cancer; morbidity; mortality; systemic treatment

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies Idioma: En Revista: Oncol Lett Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google